Health Canada drug identification number

DIN 02166712 — SANDOZ TIMOLOL 0.25 %

SANDOZ TIMOLOL is a solution of Timolol Maleate marketed by SANDOZ CANADA INCORPORATED. The full Timolol Maleate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02166712
Brand name
SANDOZ TIMOLOL
Active ingredient
Timolol Maleate
Strength
0.25 %
Dosage form
SOLUTION
Route
OPHTHALMIC
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Non-selective beta-adrenergic blocker (ophthalmic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Timolol Maleate products

DINBrandStrengthFormManufacturerStatus
00755826 APO-TIMOP 0.25 % SOLUTION APOTEX INC DORMANT
00755834 APO-TIMOP 0.5 % SOLUTION APOTEX INC DORMANT
02290812 APO-TIMOP GEL 0.5 % SOLUTION (EXTENDED-RELEASE) APOTEX INC DORMANT
02447800 JAMP-TIMOLOL 0.5 % SOLUTION JAMP PHARMA CORPORATION MARKETED
02010259 ODAN-TIMOLOL 0.25 % SOLUTION ODAN LABORATORIESLTD DORMANT
02010240 ODAN-TIMOLOL 0.5 % SOLUTION ODAN LABORATORIESLTD DORMANT
02083353 PMS-TIMOLOL 0.25 % SOLUTION PHARMASCIENCE INC DORMANT
02083345 PMS-TIMOLOL 0.5 % SOLUTION PHARMASCIENCE INC DORMANT
02166720 SANDOZ TIMOLOL 0.5 % SOLUTION SANDOZ CANADA INCORPORATED MARKETED
00755850 TIMOLOL 10 MG TABLET AA PHARMA INC MARKETED
00755869 TIMOLOL 20 MG TABLET AA PHARMA INC MARKETED
00755842 TIMOLOL 5 MG TABLET AA PHARMA INC MARKETED
02242275 TIMOLOL MALEATE-EX 0.25 % SOLUTION (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02242276 TIMOLOL MALEATE-EX 0.5 % SOLUTION (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
00451207 TIMOPTIC 0.5 % SOLUTION ELVIUM LIFE SCIENCES MARKETED
02171899 TIMOPTIC-XE 0.5 % SOLUTION (EXTENDED-RELEASE) ELVIUM LIFE SCIENCES MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.